HLDA-221

Overview

HLDA-221 is a non-covalent regulated induced proximity targeting chimeras ( RIPTAC) . The binding of HLDA-221 to BRD4-BD1 is significantly increased after pre-incubation with FKBP . HLDA-221 can be used in cancer research.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > Epigenetic Reader Domain

Product Information

• Catalog No.: HY-156820
• CAS No.: 3077339-82-0
• Molecular Formula: C64H78ClN7O13S
• Molecular Weight: 1220.86
• Purity: 99.24%
• Storage: -20°C, protect from light, stored under nitrogen * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)
• Availability: In-stock

Source

Original product source